Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A genome-wide association scan on estrogen receptor-negative breast cancer.
Li J, Humphreys K, Darabi H, Rosin G, Hannelius U, Heikkinen T, Aittomäki K, Blomqvist C, Pharoah PD, Dunning AM, Ahmed S, Hooning MJ, Hollestelle A, Oldenburg RA, Alfredsson L, Palotie A, Peltonen-Palotie L, Irwanto A, Low HQ, Teoh GH, Thalamuthu A, Kere J, D'Amato M, Easton DF, Nevanlinna H, Liu J, Czene K, Hall P. Li J, et al. Among authors: kere j. Breast Cancer Res. 2010;12(6):R93. doi: 10.1186/bcr2772. Epub 2010 Nov 9. Breast Cancer Res. 2010. PMID: 21062454 Free PMC article.
Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma.
Smedby KE, Lindgren CM, Hjalgrim H, Humphreys K, Schöllkopf C, Chang ET, Roos G, Ryder LP, Falk KI, Palmgren J, Kere J, Melbye M, Glimelius B, Adami HO. Smedby KE, et al. Among authors: kere j. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):258-65. doi: 10.1158/1055-9965.EPI-05-0583. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492913
Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Pylkäs K, Tommiska J, Syrjäkoski K, Kere J, Gatei M, Waddell N, Allinen M, Karppinen SM, Rapakko K, Kääriäinen H, Aittomäki K, Blomqvist C, Mustonen A, Holli K, Khanna KK, Kallioniemi OP, Nevanlinna H, Winqvist R. Pylkäs K, et al. Among authors: kere j. Carcinogenesis. 2007 May;28(5):1040-5. doi: 10.1093/carcin/bgl237. Epub 2006 Dec 13. Carcinogenesis. 2007. PMID: 17166884
Large-scale zygosity testing using single nucleotide polymorphisms.
Hannelius U, Gherman L, Mäkelä VV, Lindstedt A, Zucchelli M, Lagerberg C, Tybring G, Kere J, Lindgren CM. Hannelius U, et al. Among authors: kere j. Twin Res Hum Genet. 2007 Aug;10(4):604-25. doi: 10.1375/twin.10.4.604. Twin Res Hum Genet. 2007. PMID: 17708702
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease.
D'Amato M, Bruce S, Bresso F, Zucchelli M, Ezer S, Pulkkinen V, Lindgren C, Astegiano M, Rizzetto M, Gionchetti P, Riegler G, Sostegni R, Daperno M, D'Alfonso S, Momigliano-Richiardi P, Torkvist L, Puolakkainen P, Lappalainen M, Paavola-Sakki P, Halme L, Farkkila M, Turunen U, Kontula K, Lofberg R, Pettersson S, Kere J. D'Amato M, et al. Among authors: kere j. Gastroenterology. 2007 Sep;133(3):808-17. doi: 10.1053/j.gastro.2007.06.012. Epub 2007 Jun 20. Gastroenterology. 2007. PMID: 17854592
PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease.
Zucchelli M, Torkvist L, Bresso F, Halfvarson J, Hellquist A, Anedda F, Assadi G, Lindgren GB, Svanfeldt M, Janson M, Noble CL, Pettersson S, Lappalainen M, Paavola-Sakki P, Halme L, Färkkilä M, Turunen U, Satsangi J, Kontula K, Löfberg R, Kere J, D'Amato M. Zucchelli M, et al. Among authors: kere j. Inflamm Bowel Dis. 2009 Oct;15(10):1562-9. doi: 10.1002/ibd.20963. Inflamm Bowel Dis. 2009. PMID: 19462432
608 results